related documents
- Corticosteroids in chikungunya viral polyarthritis in two Canadian travelers Conferences
- Efficacy and safety of adalimumab (Humira (R)) in Canadian clinical practice: Results from the canact trial Conferences
- Efficacy of adalimumab (Humira (R)) in Canadian clinical practice: Subanalysis of the canact trial for patients with moderate vs. severe rheumatoid arthritis Conferences
- Prolonged efficacy of rituximab in rheumatoid arthritis patients and inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (reflex study) Conferences
- Rituximab improves health-related quality of life as measured by the SF-36: Domain score results from the reflex study Conferences
- Smoldering RA: Is the Canadian health care system neglecting a significant disease population? Conferences
- Transition to electronic medical records: What rheumatologists need to know. Conferences
- Use of biologic response modifying drugs by Ontario rheumatology specialists. Conferences